Improving the reporting of Clinical trials of infertility treatments (IMPRINT): Modifying the CONSORT statement

Human Reproduction

Volumn 29, Issue 10, 2014, Pages 2075-2082

  Legro, Richard S ^b   Wu, Xiaoke ^a   Barnhart, Kurt T ^b   Farquhar, Cynthia ^b   Fauser, Bart C J M ^b   Mol, Ben ^b  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

CONSORT; Imprint; Infertility trial; Modification; Reporting

Indexed keywords

ARTICLE; CONSENSUS DEVELOPMENT; FEMALE; HUMAN; INFERTILITY THERAPY; LIVE BIRTH; MALE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; ADVERSE EFFECTS; CHINA; CLINICAL TRIAL (TOPIC); FOLLOW UP; INFERTILITY; METHODOLOGY; PREGNANCY; PREGNANCY OUTCOME; STANDARDS;

CHINA; CLINICAL TRIALS AS TOPIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFERTILITY; MALE; PREGNANCY; PREGNANCY OUTCOME; REPRODUCTIVE TECHNIQUES, ASSISTED; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 84965090539     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu218     Document Type: Article

References (23)

1. Battaglia FC, Lubchenco LO. A practical classification of newborn infants by weight and gestational age. J Pediatr 1967;71:159-163.
2. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, Group C. Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Ann Intern Med 2008;148:W60-W66.
3. Bulletins-Obstetrics ACoP. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002;99:159-167.
4. Clarke JF, van Rumste MM, Farquhar CM, Johnson NP, Mol BW, Herbison P. Measuring outcomes in fertility trials: can we rely on clinical pregnancy rates? Fertil Steril 2010;94:1647-1651.
5. Dapuzzo L, Seitz FE, Dodson WC, Stetter C, Kunselman AR, Legro RS. Incomplete and inconsistent reporting of maternal and fetal outcomes in infertility treatment trials. Fertil Steril 2011;95:2527-2530.
6. Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C, CONSORT Group. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med 2006;144:364-367.
7. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leiva Ad, Hod M, Kitzmiler JL et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676-682.
8. Johnson NP. No more surrogate end-points in randomised trials: The PCOSMIC trial protocol for women with polycystic ovary syndrome using metformin for infertility with clomiphene. Aust N Z J Obstet Gynaecol 2006;46:141-145.
9. Johnson NP, Proctor M, Farquhar CM. Gaps in the evidence for fertility treatment-an analysis of the Cochrane Menstrual Disorders and Subfertility Group database. Hum Reprod 2003;18:947-954.
10. Legro RS, Myers E. Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome? Hum Reprod 2004;19:1697-1704.
11. MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White A, Moher D; STRICTA Revision Group. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. PLoS Med 2010;7:e1000261.
12. McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 1999;340:1234-1238.
13. Min JK, Breheny SA, MacLachlan V, Healy DL. What is the most relevant standard of success in assisted reproduction? The singleton, term gestation, live birth rate per cycle initiated: the BESST endpoint for assisted reproduction. Hum Reprod 2004;19:3-7.
14. Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers ofhealth research reporting guidelines. PLoS Med 2010;7:e1000217.
15. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ, Group C. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA 2006;295:1152-1160.
16. Practice Committee of the American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril 2003;80:1309-1314.
17. Schlaff WD. Barrierstoconducting clinical researchinreproductive medicine around the world. Fertil Steril 2011;96:801.
18. Schulz KF, Altman DG, Moher D, Group C. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Obstet Gynecol 2010;115:1063-1070.
19. Spong CY. Defining 'term' pregnancy: recommendations from the Defining 'Term' Pregnancy Workgroup. JAMA 2013;309:2445-2446.
20. Vail A, Gardener E. Common statistical errors in the design and analysis of subfertility trials. Hum Reprod 2003;18:1000-1004.
21. Vandorsten JP, Dodson WC, Espeland MA, Grobman WA, Guise JM, Mercer BM, Minkoff HL, Poindexter B, Prosser LA, Sawaya GF et al. NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements 2013;29:1-31.
22. Wennerholm UB, Bergh C. What is the most relevant standard of success in assisted reproduction? Singleton live births should also include preterm births. Hum Reprod 2004;19:1943-1945.
23. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. Geneva, Switzerland: World Health Organization, 1993, 129.